Your session is about to expire
← Back to Search
Electronic Health Record Strategies for Patient Engagement
N/A
Waitlist Available
Led By Brian Smith, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial will study whether adding banners, a chatbot, and direct messaging to an online patient portal will increase interest in research among portal users.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of patients who create a research profile
Secondary outcome measures
Number of patients who enroll in a research study
Trial Design
16Treatment groups
Experimental Treatment
Active Control
Group I: Traditional Letter OnlyExperimental Treatment1 Intervention
*A mailed letter will invite the patient to set up a research profile in their patient portal.
Group II: Traditional Letter + Direct to Patient Message + Chatbot + BannerExperimental Treatment4 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND
An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND
A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests; AND
Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group III: Traditional Letter + Direct to Patient Message + ChatbotExperimental Treatment3 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND
An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND
A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Group IV: Traditional Letter + Direct to Patient Message + BannerExperimental Treatment3 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND
An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND
Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group V: Traditional Letter + Direct to Patient MessageExperimental Treatment2 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND
An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research.
Group VI: Traditional Letter + Chatbot + BannerExperimental Treatment3 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND
A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
AND
*Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group VII: Traditional Letter + ChatbotExperimental Treatment2 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND
A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Group VIII: Traditional Letter + BannerExperimental Treatment2 Interventions
A mailed letter will invite the patient to set up a research profile in their patient portal; AND
Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group IX: Direct to Patient Message OnlyExperimental Treatment1 Intervention
*An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research.
Group X: Direct to Patient Message + Chatbot + BannerExperimental Treatment3 Interventions
An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND
A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests; AND
Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group XI: Direct to Patient Message + ChatbotExperimental Treatment2 Interventions
An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research; AND
A real-time, interactive chatbot will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Group XII: Direct to Patient Message + BannerExperimental Treatment2 Interventions
An e-mail sent to the patient will inform the patient that there is a message pending in their patient portal regarding opportunities to participate in research AND
Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group XIII: Chatbot OnlyExperimental Treatment1 Intervention
*A real-time, interactive chatbot on the patient portal will encourage research participation and direct patients to learn more about research opportunities and trials that match their interests.
Group XIV: Chatbot + BannerExperimental Treatment2 Interventions
A real-time, interactive chatbot will encourage research participation and direct patients to learn more about clinical trial opportunities and trials that match their interests; AND
Banner-type "advertisements" during routine viewing and use of of the patient's portal for their our medical/clinical care will inform patients of research opportunities.
Group XV: Banner OnlyExperimental Treatment1 Intervention
*Banner-type "advertisements" will appear during routine viewing and use of of the patient's portal for their our medical/clinical care inform patients of research opportunities.
Group XVI: No InterventionActive Control1 Intervention
*No intervention.
Find a Location
Who is running the clinical trial?
Food and Drug Administration (FDA)FED
171 Previous Clinical Trials
605,407 Total Patients Enrolled
Yale UniversityLead Sponsor
1,848 Previous Clinical Trials
2,011,619 Total Patients Enrolled
Brian Smith, MDPrincipal InvestigatorYale School of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have chosen not to participate in the study.You are already participating in another clinical trial.You are currently receiving treatment for cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Banner Only
- Group 2: Direct to Patient Message + Chatbot + Banner
- Group 3: Traditional Letter + Banner
- Group 4: Direct to Patient Message + Chatbot
- Group 5: Traditional Letter + Direct to Patient Message + Chatbot
- Group 6: Traditional Letter + Chatbot + Banner
- Group 7: Traditional Letter + Direct to Patient Message + Chatbot + Banner
- Group 8: No Intervention
- Group 9: Traditional Letter + Direct to Patient Message
- Group 10: Traditional Letter Only
- Group 11: Chatbot Only
- Group 12: Traditional Letter + Chatbot
- Group 13: Direct to Patient Message Only
- Group 14: Direct to Patient Message + Banner
- Group 15: Traditional Letter + Direct to Patient Message + Banner
- Group 16: Chatbot + Banner
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any further participants needed for this trial?
"Indeed, the information on clinicaltrials.gov reveals that this trial is open to recruitment. It was initially posted on September 13th 2022 and was last updated on October 18th 2022. The study seeks to enrol 750 thousand patients from a single site."
Answered by AI
How many participants are being included in this research project?
"Correct. According to clinicaltrials.gov, this ongoing medical study is still seeking participants and was initially posted on September 13th 2022. This experiment requires the recruitment of 750 thousand people from a single location."
Answered by AI
Share this study with friends
Copy Link
Messenger